Home › Ligand Signs License Agreement With Sermonix For Lasofoxifene
 

Keywords :   


Ligand Signs License Agreement With Sermonix For Lasofoxifene

2015-02-04 06:55:23| drugdiscoveryonline Home Page

Ligand Pharmaceuticals Incorporated announces the signing of a license agreement with Sermonix Pharmaceuticals LLC for the development and commercialization of oral lasofoxifene in the United States and additional territories

Tags: agreement license signs license agreement

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
14.11AKB48 1st
14.11kindle 10
14.11
14.11YAMAHA PORTATONE PSR-340
14.112003 112
14.11 14533.5
14.11caligari 17
14.11 amnjx 27circus
More »